Based on the features of HIV-1 VLP, we would like to hypothesize that HIV-1 VLP may play a role as antigen for DC-based therapy and that the native Env trimers displayed on the VLP may also facilitate the development of broadly neutralizing antibody responses, which are beneficial for the control of viral load and clinical of progression of HIV infection. Here, ERVW-1 is linked to HIV infectious disease.